Genomics

Dataset Information

0

The TBK1/IKKe Inhibitor Amlexanox Improves Dyslipidemia and Prevents Atherosclerosis


ABSTRACT: Cardiovascular diseases, especially atherosclerosis and its complications, are a leading cause of death. Inhibition of the non-canonical IkB kinases TBK1 and IKKe with amlexanox restores insulin sensitivity and glucose homeostasis in diabetic mice and human subjects. Here we report that amlexanox improves diet-induced hypertriglyceridemia and hypercholesterolemia in Western diet (WD)-fed Ldlr-/- mice, and protects against atherogenesis. Amlexanox ameliorates dyslipidemia, inflammation and vascular dysfunction through synergistic actions that involve upregulation of bile acid synthesis to increase cholesterol excretion. Transcriptomic profiling demonstrates an elevated expression of key bile acid synthesis genes. Furthermore, we found that amlexanox attenuates monocytosis, eosinophilia and vascular dysfunction during WD-induced atherosclerosis. These findings demonstrate the potential of amlexanox as a new therapy for hypercholesterolemia and atherosclerosis.

ORGANISM(S): Mus musculus

PROVIDER: GSE209621 | GEO | 2022/07/27

REPOSITORIES: GEO

Similar Datasets

2012-11-16 | GSE42320 | GEO
2012-11-16 | E-GEOD-42320 | biostudies-arrayexpress
2015-07-09 | E-GEOD-70619 | biostudies-arrayexpress
2015-07-09 | GSE70619 | GEO
2021-04-13 | GSE113538 | GEO
2020-03-30 | GSE140412 | GEO
2007-01-31 | GSE6837 | GEO
2016-03-11 | E-GEOD-79074 | biostudies-arrayexpress
2008-06-15 | E-GEOD-6837 | biostudies-arrayexpress
2022-04-04 | PXD030951 | Pride